Do you have myelofibrosis?

Similar documents
No Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)

2010 International Nanny Association Salary and Benefits Survey Information in this report is based on the year About Survey Respondents

Volunteering in Oklahoma City, OK

2018 National Oncologists Workforce Study OCTOBER 2018

Zhiwei Zhang, Ph.D. National Opinion Research Center

"The Most Challenging Places to Live with Asthma"

National & International Lectures

Tuberculosis and Travel

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Retaking NPTE

UNDERSTANDING MYELOFIBROSIS (MF) A guide for patients and caregivers

SPRINT SCHEDULE NO. 11 1st Revised Page Originating Locations for Business Communications Services

*All Local Monthlies Data releases are scheduled from 9:00pm - 11:00pm for the date shown on the schedule

Ryan White Program Appropriations

PS : Comprehensive HIV Prevention Programs for Health Departments

2012 International Nanny Association Salary and Benefits Survey Information in this report is based on the year 2011

About the Symposium. About the NAGC. Past Locations

SASI Analysis of Funds Distributed in the United States By the Centers for Disease Control and Prevention (CDC) Pursuant to PS

Improving Oral Health:

Evolving Guidelines of MPNs Where do new options fit in your treatment plan?

SEC Professionals Group

FOCUS Initiative. Arun Skaria FOCUS Regional Lead, New Jersey Associate Director Government Affairs

U.S. Apartment Markets Outlook

Dr. Brian Gray 2011 Lecture Schedule

Chapter Two Incidence & prevalence

Keep Smiling. DeltaCare USA. provided by Delta Dental of California. Budget-friendly costs. Dental benefits made easy! Convenient services

IBM ServicePac Warranty Service Upgrade (WSU)

Your Smile, Your Choice

Integrated HIV Statewide Coordinated Statement of Need (SCSN)/Comprehensive Plan Update

Voluntary Mental Health Treatment Laws for Minors & Length of Inpatient Stay. Tori Lallemont MPH Thesis: Maternal & Child Health June 6, 2007

Financial Impact of Lung Cancer in West Virginia

Office of Clinical Research. Information for Participants

Integrated SCSN/Comprehensive Plans and How a Range of Integrated HIV Planning Activities Can Contribute

Questions and answers: HVTN 110 vaccine study

MHCA news alerts! Spring View this in your browser. MHCA news alerts! Spring 2014

CALENDAR OF EVENTS AUGUST/SEPTEMBER 2012

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Foreign Educated PTs and PTAs

This study is currently recruiting participants.

ClinicalTrials.gov Protocol Registration and Results System (PRS) Receipt Release Date: September 30, ClinicalTrials.gov ID: NCT

Diet Charts: The Keeper's Tool and Aide

A GUIDE TO STARTING TREATMENT

Walk. Give. To help them live. November 23

BOTCHED ABORTION REPORTS

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Foreign Educated Physical Therapists

UNDERSTANDING POLYCYTHEMIA VERA (PV) A guide for patients and caregivers

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Direct Access

OREGON MEDICAL MARIJUANA PROGRAM STATISTICAL SNAPSHOT JANUARY, 2015 (REVISED 02/26/2015)

A National Perspective on Preventing Urban Violence

Smokeless Tobacco Pricing Strategies and Policies

Reducing Barriers to Risk Appropriate Cancer Genetics Services: Current Strategies

Enroll in DeltaCare USA and you ll enjoy these features: you and your family. conditions covered,

Becoming a Sponsor Orlando February 24, 2018

Alzheimer s Association Clinical Studies Initiative

Choosing your plan. City of Sacramento. We ll do whatever it takes and then some. Your Two Delta Dental Plan Options

Quick Reference Guide for Health Care Providers

How to Get Paid for Doing EBD

Improving Access to Oral Health Care for Vulnerable and Underserved Populations

Treating sickle cell disease: Is hydroxyurea right for your child?

Lorcaserin (APD356), a Selective 5-HT5

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: License Renewal. License Renewal on Birthdays

Awareness and Education Survey, 2012 Education & Best Practices Committee

Bear Facts. Dental Care. Get the. you need! The. Smiling Stork. helps pregnant members. A HealthCare USA Member Newsletter Volume

Workforce Data The American Board of Pediatrics

NASMHPD: Peer Support Services Survey

Preventing violence before it occurs: Recognizing a public health approach

We are BEST. Real People Rapid Claims Payment Great Service

Quarterly Statistical Report

Dental ER Visits: Evidence of a Failed System. Shelly Gehshan AACDP Conference April 29, 2012

Report to Congressional Defense Committees

Melanoma. Research Alliance. Fast-Forwarding a Cure for Deadly Skin Cancer

BY-STATE MENTAL HEALTH SERVICES AND EXPENDITURES IN MEDICAID, 1999

2019 Walk4Hearing National Corporate Sponsorship Opportunities

Arkansas Prescription Monitoring Program

Federation of State Boards of Physical Therapy Jurisdiction Licensure Reference Guide Topic: Direct Access

Medicaid Expansion & Adult Dental Benefits: Access to Dental Care among Low-Income Adults

Ready Today for the. Brian Kelly, MD Aetna National Medical Director. Future of Health Care

Treating sickle cell disease: Is hydroxyurea right for you?

Jose R. Martinez, Ph.D. Joseph R. Pearson Hall 1122 W. Campus Rd., Room 506 Lawrence, KS

Hospice in ESRD: To Withdraw or Not to Withdraw

23 Sites in Convenience Sample First use of Bioassay in CJ Survey

RAISE Network Webinar Series. Asian Smokers Quitline (ASQ): Promoting Cessation in Our Communities. March 17, :00 pm 2:00 pm PT

Mexico. April August 2009: first wave

Payee State Title / Description Program Date

OREGON MEDICAL MARIJUANA PROGRAM STATISTICAL SNAPSHOT JULY, 2016 (REVISED 09/06/2016)

Expanding Contraceptive Access: Developing and Implementing State-based Approaches March 16, Co-sponsored by:

AMERICAN IMMUNIZATION REGISTRY ASSOCIATION A L I S O N C H I, P R O G R A M D I R E C T O R

we take our pants off for charity. 2018

RECOVERY SUPPORT SERVICES IN STATES

2017 EXHIBITOR GUIDE. Cities Dates Pricing Packages

2016 COMMUNITY SURVEY

GFHS BOARD OF DIRECTORS MEETING MAY 25,2016. Gaston Family Health Services

PRM 151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks

Doctor office visit checklist

2018 PHARMACY DIRECTORY

State of California Department of Justice. Bureau of Narcotic Enforcement

Use of molecular surveillance data to identify clusters of recent and rapid HIV transmission

OREGON MEDICAL MARIJUANA PROGRAM STATISTICAL SNAPSHOT JANUARY, 2015

INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support

American Council of Learned Societies Please view the ACLS websit e (

INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support

BALTIMORE CITY HIV/AIDS EPIDEMIOLOGICAL PROFILE Second Quarter Data reported through June 30, 2008

Transcription:

Do you have myelofibrosis? Learn more about a clinical study.

What Is a Clinical Study? A clinical study is a way to evaluate a drug in people with a certain illness. Some clinical studies (or clinical trials ) investigate drugs that doctors cannot yet prescribe. A goal of a clinical study is to learn if a study drug is safe and effective for people to take. Effective means it helps in some way to use the study drug for a certain disease or condition. To learn more about clinical studies in general, refer to https://www.fda.gov/forpatients/clinicaltrials/ucm407821.htm. What Is This Clinical Study About? In this study, 2 drugs will be studied together. One of the study drugs is an investigational drug. This means the drug is not approved by the US Food and Drug Administration for use in myelofibrosis (MF). Incyte, the company that developed the study drug, is the study sponsor. Among other things, the study will examine If your spleen size is reduced If your MF symptoms are reduced What the side effects are when taking the 2 study drugs together Talk to your doctor if you are interested in participating in this study. To find a study center near you, call, then select option 1. You can also visit clinicaltrials.gov and enter NCT02718300 to learn more. 2

How Do I Know if I Qualify for the Study? INCLUSION CRITERIA Every study has guidelines to help determine if a person is eligible to take part or not. Inclusion criteria are all the things that must be true for you to join a study. For this study, some of these include You must be at least 18 years old You must be diagnosed with MF You must be currently taking ruxolitinib for a certain period of time at a certain dose You must have an enlarged spleen, despite treatment with ruxolitinib You must have had a bone marrow biopsy or be willing to undergo a bone marrow biopsy Enlarged spleen EXCLUSION CRITERIA Exclusion criteria are all the things that would prevent you from joining a study. For this study, some of these include You are taking or have taken another study drug for MF in the past 6 months You are unable to swallow food or pills You are unwilling to undergo a blood transfusion Your liver function, kidney function, or blood cell counts do not meet study criteria To find out if you can be in the study, call this number:, then select option 1. You may have to answer some pre-screening questions. 3

What Else Would I Need to Do if I Want to Join the Study? You will need to get a complete physical exam to see if you are eligible for the study. During that screening, you may need to Give blood and urine samples Have a bone marrow biopsy if you have not had one before How Long Will I Be in the Study? You may be in the study for up to approximately 24 months. What Will Be Expected of Me During the Study? Throughout the study You will need to take all study-related drugs as instructed You will get regular checkups and visits with the study team You will have at least 12 lab visits for blood work or other tests You will need to have a bone marrow biopsy every 24 weeks while participating in the study A study team will stay in close contact with you to see how you are feeling and answer any questions you may have. Talk to your doctor if you are interested in participating in this study. To find a study center near you, call, then select option 1. You can also visit clinicaltrials.gov and enter NCT02718300 to learn more. 4

What Costs May Be Covered During the Study? The study drugs will be provided at no cost to you. Your health plan may cover costs for your routine medical care. The study team may help you check with your health plan and your doctor about any costs related to the study. You will not be paid for being in the study. You should learn before joining this study Which part of the research-related care will be free Which costs your insurer will pay; which costs you will have to pay If you will be reimbursed for travel costs up to a certain amount per visit Are There Benefits and Risks to Being in This Study? Your current doctor who is managing your MF is the best person to help you understand the possible benefits and risks of joining this study. Below are 2 websites that can help you start a conversation https://www.nhlbi.nih.gov/studies/clinicaltrials/benefitsrisks https://www.nih.gov/health-information/nih-clinical-research-trials-you/basics To find out if you can be in the study, call this number:, then select option 1. You may have to answer some pre-screening questions. 5

Is There a Study Center Near Me? Review the map to find the study center nearest to you. To get the address and phone number of a study center, call the number below. You can also visit clinicaltrials.gov and enter NCT02718300 to learn more. Portland, OR Minneapolis, MN Ames, IA Chicago, IL Indianapolis, IN Cincinnati, OH Cleveland, OH Buffalo, NY Boston, MA Bronx, NY New York, NY Hackensack, NJ Morristown, NJ Baltimore, MD Louisville, KY St. Louis, MO Los Angeles, CA Duarte, CA Salt Lake City, UT Westwood, KS Atlanta, GA Birmingham, AL Gainesville, FL San Antonio, TX Houston, TX To learn more about this clinical study, call, then select option 1. You can also visit clinicaltrials.gov and enter NCT02718300 to learn more. 2017 Incyte Corporation. All Rights Reserved.